SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-24-002679
Filing Date
2024-01-08
Accepted
2024-01-08 07:00:36
Documents
14
Period of Report
2024-01-08
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K pepg-20240108.htm   iXBRL 8-K 37661
2 EX-99.1 pepg-ex99_1.htm EX-99.1 25116
3 GRAPHIC img148377401_0.jpg GRAPHIC 9190
  Complete submission text file 0000950170-24-002679.txt   200886

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT pepg-20240108_lab.xml EX-101.LAB 13896
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT pepg-20240108_pre.xml EX-101.PRE 10218
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT pepg-20240108.xsd EX-101.SCH 2451
8 EXTRACTED XBRL INSTANCE DOCUMENT pepg-20240108_htm.xml XML 4873
Mailing Address 1 MARINA PARK DRIVE, SUITE 900 BOSTON MA 02210
Business Address 1 MARINA PARK DRIVE, SUITE 900 BOSTON MA 02210 703-456-8000
PepGen Inc. (Filer) CIK: 0001835597 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41374 | Film No.: 24518267
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)